Chengzhi Co., Ltd.

Chengzhi Co., Ltd. is a high-tech manufacturing company listed on the Shenzhen Stock Exchange since 2000. Controlled by Tsinghua University, it serves as a strategic enterprise under Tsinghua Holdings and is recognized as a key enterprise in Jiangxi Province. The company focuses on sectors such as new energy, functional materials, and health care, acting as an industrial platform to facilitate the transformation of scientific research achievements in these areas. Chengzhi operates primarily in three business lines. In the new energy sector, it produces industrial gases and basic chemical raw materials, establishing partnerships with major petrochemical companies. Its functional materials division is a leading supplier of liquid crystal materials, holding significant market shares in both the TN and STN liquid crystal markets globally. In health care, the company manages hospitals and medical service institutions, specializing in hospital investment management and the development of natural fermented products like D-ribose, where it has achieved notable advancements and holds complete intellectual property rights.

1.New energy business: depending on its advanced production equipment and technologies, the Company has continuously intensified technical innovation and new product development by making use of its exclusivity and geographical advantages in the gas business, which made it a model of energy conservation and emission reduction as well as development of circular economy in Nanjing Chemical Industry Park. Its subsidiary, Anhui Baolong Environmental Protect Technology Co., Ltd., has successively undertaken three projects under the national 863 Program, one project under China Torch Program, and one central government investment project, presided over and participated in the establishment of national industrial standards and local standards. Its technical achievements won the second prize of the National Award for Science and Technology Progress and the first prize of the Award of the Ministry of Environmental Protection for Environmental Science Progress. 2.Functional material business: the Company possesses several invention patents in the LCD material field, takes the lead in China in terms of the annual processing capacity of liquid crystal monomers and intermediates as well as the annual production capacity of TFT mixing liquid crystal, and ranks first in the global sales of monochromatic liquid crystal materials. It holds a market share of more than 70% in the global TN liquid crystal material market and a market share of 40% in the global STN liquid crystal material market. It was listed among China’s dominant enterprises in intellectual property in 2016. 3.Health care business: the Company has held a leading position in the world in D-ribose product application development. Its project named “D-ribose production by the fermentation method” has been incorporated into the National Innovation Program, National New Products Program, National Biological Structure Adjustment and Industrial Upgrade Program. It has also held a controlling stake in a tertiary, Grade A hospital—Dandong First Hospital, which is a teaching hospital of China Medical University and other universities, and had 20 wards, 45 departments and 1,080 beds by the end of 2016.